We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current BIOL market cap is 370.01k. The company's latest EPS is USD -16.3790 and P/E is -0.01.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.05M | 10.47M | 14.29M | 10.92M | 13.49M |
| Operating Income | -8.43M | -5.29M | -3.87M | -3.7M | -5.08M |
| Net Income | -10.08M | -5.85M | -4.87M | -4.59M | -22.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37.8M | 22.78M | 39.19M | 48.46M | 49.16M |
| Operating Income | -15.62M | -18.54M | -16.43M | -25.34M | -17.94M |
| Net Income | -17.86M | -34.21M | -16.7M | -28.85M | -37.62M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.19M | 41.94M | 39.63M | 38.75M | 35.1M |
| Total Liabilities | 33.3M | 33.79M | 32.29M | 32.86M | 33.15M |
| Total Equity | 4.89M | 8.16M | 6.62M | 332k | -247k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.85M | 41.03M | 55.28M | 38.19M | 35.1M |
| Total Liabilities | 27.51M | 31M | 30.08M | 33.3M | 33.15M |
| Total Equity | 377k | 10.03M | 25.21M | 4.89M | -247k |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.76M | -5.66M | -9.22M | -11.81M | -14.09M |
| Investing | -3.73M | -587k | -944k | -1.13M | -1.13M |
| Financing | 4.6M | 8.52M | 12.79M | 16.55M | 17.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.75M | -12.8M | -16.71M | -26.76M | -14.09M |
| Investing | -207k | -96k | -707k | -3.73M | -1.13M |
| Financing | 10.72M | 24.35M | 29.95M | 4.6M | 17.43M |
| Market Cap | 370.01k |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0.01 |
| Price to Cash Ratio | 0.06 |
| Price to Book Ratio | 0.21 |
| Dividend Yield | - |
| Shares Outstanding | 2.3M |
| Average Volume (1 week) | 1.74M |
| Average Volume (1 Month) | 1.06M |
| 52 Week Change | -99.27% |
| 52 Week High | 23.32 |
| 52 Week Low | 0.1251 |
| Spread (Intraday) | 0.01 (4.84%) |
| Company Name | Biolase Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.biolase.com |
| Industry | dental equipment & supplies (3843) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
